Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) Stock
Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company that engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
Peer Comparison
About Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company that engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products. Its portfolio includes products for the cardio-cerebral vascular system, as well as segments for innovative medicine, generic medicine, and medical aesthetics which includes injectables, energy-based devices, and skincare solutions. The company operates primarily in the People's Republic of China, with some international presence.
Sihuan Pharmaceutical Holdings Group Ltd. is led by CEO Wei Cheng Guo, employs 2,843 people, headquartered in Beijing, HK, publicly traded since 2010.
over the past 52 weeks the stock has ranged between $0.82 and $1.92, and currently trades 54.2% below its 52-week high.
Official website: www.sihuanpharm.com